Kanada - englanti - Health Canada

pro doc limitee - leflunomide - tablet - 10mg - leflunomide 10mg - disease-modifying antirheumatic agents

Kanada - englanti - Health Canada

pro doc limitee - leflunomide - tablet - 20mg - leflunomide 20mg - disease-modifying antirheumatic agents

Kanada - englanti - Health Canada

odan laboratories ltd - leflunomide - tablet - 10mg - leflunomide 10mg - disease-modifying antirheumatic agents

Kanada - englanti - Health Canada

odan laboratories ltd - leflunomide - tablet - 20mg - leflunomide 20mg - disease-modifying antirheumatic agents

Yhdysvallat - englanti - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

Yhdysvallat - englanti - NLM (National Library of Medicine)

marlex pharmaceuticals inc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

Yhdysvallat - englanti - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

Yhdysvallat - englanti - NLM (National Library of Medicine)

lannett company, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

Yhdysvallat - englanti - NLM (National Library of Medicine)

carilion materials management - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate,paracetamol -